Cargando…
Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy
PURPOSE: To investigate long-term treatment response after intravitreal bevacizumab injections (IVBIs) for central serous chorioretinopathy (CSC). METHODS: This retrospective, interventional study investigated the medical records of 45 eyes of 44 patients with CSC who underwent IBVIs and completed a...
Autores principales: | Kang, Hae Min, Choi, Jeong Hoon, Koh, Hyoung Jun, Lee, Sung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478837/ https://www.ncbi.nlm.nih.gov/pubmed/32898167 http://dx.doi.org/10.1371/journal.pone.0238725 |
Ejemplares similares
-
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016) -
The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
por: Maleki, Alireza, et al.
Publicado: (2018) -
The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
por: Lim, Ji Won, et al.
Publicado: (2010) -
Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy
por: Chung, Yoo-Ri, et al.
Publicado: (2022) -
Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
por: Alishiri, Aliagha, et al.
Publicado: (2019)